Skip to main content

Advertisement

Log in

Hormone profile in juvenile systemic lupus erythematosus with previous or current amenorrhea

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

To identify the underlying mechanism of amenorrhea in juvenile systemic lupus erythematosus (JSLE) patients, thirty-five (11.7%) JSLE patients with current or previous amenorrhea were consecutively selected among the 298 post-menarche patients followed in 12 Brazilian pediatric rheumatology centers. Pituitary gonadotrophins [follicle-stimulating hormone (FSH) and luteinizing hormone (LH)] and estradiol were evaluated in 32/35 patients, and prolactin and total testosterone in 29/35 patients. Patient’s medical records were carefully reviewed according to demographic, clinical and therapeutic findings. The mean duration of amenorrhea was 7.2 ± 3.6 months. Low FSH or LH was observed in 7/32 (22%) JSLE patients and normal FSH or LH in 25 (78%). Remarkably, low levels of FSH or LH were associated with higher frequency of current amenorrhea (57% vs. 0%, P = 0.001), higher median disease activity (SLEDAI) and damage (SLICC/ACR-DI) (18 vs. 4, P = 0.011; 2 vs. 0, P = 0.037, respectively) and higher median current dose of prednisone (60 vs. 10 mg/day, P = 0.0001) compared to normal FSH or LH JSLE patients. None of them had decreased ovarian reserve and premature ovarian failure. Six of 29 (21%) patients had high levels of prolactin, and none had current amenorrhea. No correlations were observed between levels of prolactin and SLEDAI, and levels of prolactin and SLICC/ACR-DI scores (Spearman′s coefficient). We have identified that amenorrhea in JSLE is associated with high dose of corticosteroids indicated for active disease due to hypothalamic-pituitary-ovary axis suppression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gurtcheff S, Hatasaka H (2006) Fertility and autoimmune disease. In: Lockshin M, Branch W (eds) Handbook of systemic autoimmune disease. Reproductive and hormonal aspects of systemic autoimmune disease, vol 4. Elsevier, Amsterdam, pp 29–42

    Chapter  Google Scholar 

  2. Schaller J (1982) Lupus in childhood. Clin Rheum Dis 8:219–228

    PubMed  CAS  Google Scholar 

  3. Silva CA, Leal MM, Leone C et al (2002) Gonadal function in adolescents and young female with systemic lupus erythematosus. Lupus 11:419–425. doi:10.1191/0961203302lu219oa

    Article  PubMed  CAS  Google Scholar 

  4. Silva CA, Hilário MO, Febrônio MV et al (2007) Risk factors for amenorrhea in juvenile systemic lupus erythematosus (JSLE): a Brazilian multicentre cohort study. Lupus 16:531–536. doi:10.1177/0961203307079300

    Article  PubMed  CAS  Google Scholar 

  5. Medeiros PB, Mv Febronio, Bonfa E, Borba EF, Takiuti AD, Silva CA (2009) Menstrual and hormonal alteration in juvenile systemic lupus erythematosus. Lupus 18:38–43. doi:10.1177/0961203308094652

    Article  PubMed  CAS  Google Scholar 

  6. Silva CA, Brunner HI (2007) Gonadal functioning and preservation of reproductive fitness with juvenile systemic lupus erythematosus. Lupus 16:593–599. doi:10.1177/0961203307077538

    Article  PubMed  CAS  Google Scholar 

  7. Metcalf MG, Skidmore D, Lowry GF, Mackenzie JA (1983) Incidence of ovulation in the years after the menarche. J Endocrinol 97:213–219. doi:10.1677/joe.0.0970213

    Article  PubMed  CAS  Google Scholar 

  8. Shabanova SS, Ananieva LP, Alekberova ZS, Guzov II (2008) Ovarian function and disease activity in patients with systemic lupus erythematosus. Clin Exp Rheumatol 26:436–441

    PubMed  CAS  Google Scholar 

  9. Ronchezel MV, Len CA, Spinola e Castro A et al (2001) Thyroid function and serum prolactin levels in patients with juvenile systemic lupus erythematosus. J Pediatr Endocrinol Metab 14:165–169

    PubMed  CAS  Google Scholar 

  10. Boumpas DT, Austin HA, Vaughan EM, Yarboro CH, Klippel JH, Balow JE (1993) Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 119:366–369

    PubMed  CAS  Google Scholar 

  11. Wang CL, Wang F, Bosco JJ (1995) Ovarian failure in oral cyclophosphamide treatment for systemic lupus erythematosus. Lupus 4:11–14. doi:10.1177/096120339500400103

    Article  PubMed  CAS  Google Scholar 

  12. Mok CC, Lau CS, Wong RW (1998) Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy. Arthritis Rheum 41:831–837. doi:10.1002/1529-0131(199806)41:6<1090:AID-ART16>3.0.CO;2-6

    Article  PubMed  CAS  Google Scholar 

  13. Fatnoon NN, Azarisman SM, Zainal D (2008) Prevalence and risk factors for menstrual disorders among systemic lupus erythematosus patients. Singapore Med J 49:413–418

    PubMed  CAS  Google Scholar 

  14. Gonzalez-Crespo MR, Gomez-Reino JJ, Merino R et al (1995) Menstrual disorders in girls with systemic lupus erythematosus treated with cyclophosphamide. Br J Rheumatol 34:737–741. doi:10.1093/rheumatology/34.8.737

    Article  PubMed  CAS  Google Scholar 

  15. Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM (2002) Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 46:436–444. doi:10.1002/art.10072

    Article  PubMed  Google Scholar 

  16. Brunner HI, Bishnoi A, Barron AC et al (2006) Disease outcomes and ovarian function of childhood-onset systemic lupus erythematosus. Lupus 15:198–206. doi:10.1191/0961203306lu2291oa

    Article  PubMed  CAS  Google Scholar 

  17. Ravelli A, Duarte-Salazar C, Buratti S et al (2003) Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study. Arthritis Rheum 49:501–507. doi:10.1002/art.11205

    Article  PubMed  Google Scholar 

  18. Saketos M, Sharma N, Santoro NF (1993) Suppression of the hypothalamic-pituitary-ovarian axis in normal women by glucocorticoids. Biol Reprod 49:1270–1276. doi:10.1095/biolreprod49.6.1270

    Article  PubMed  CAS  Google Scholar 

  19. Pasoto SG, Mendonça BB, Bonfá E (2002) Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations. Lupus 11:175–180. doi:10.1191/0961203302lu163oa

    Article  PubMed  CAS  Google Scholar 

  20. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725. doi:10.1002/art.1780400928

    Article  PubMed  Google Scholar 

  21. Marshall JC, Tanner JM (1970) Variations in patterns of pubertal changes in boys and girls. Arch Dis Child 45:13–23. doi:10.1136/adc.45.239.13

    Article  PubMed  CAS  Google Scholar 

  22. Zerwes EP, Ferreira C, Zerwes FP, Horta BL (1995) Regularidade do ciclo menstrual pós menarca. Rev Bras Ginecol Obstet 17:76–78

    Google Scholar 

  23. Huong DL, Amoura Z, Duhaut P et al (2002) Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients. J Rheumatol 29:2571–2576

    PubMed  CAS  Google Scholar 

  24. Niaudet P (2000) Treatment of lupus nephritis in children. Pediatr Nephrol 14:158–166. doi:10.1007/s004670050034

    Article  PubMed  CAS  Google Scholar 

  25. Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM (1999) Sensitivity of the systemic lupus erytematosus disease activity index, British Isles lupus assessment group index, and systemic lupus activity measure in the evaluation of clinical change in childhood-onset systemic lupus erytematosus. Arthritis Rheum 42:1354–1360. doi:10.1002/1529-0131(199907)42:7<1354:AID-ANR8>3.0.CO;2-4

    Article  PubMed  CAS  Google Scholar 

  26. Gladman D, Urowitz M, Fortin P et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369. doi:10.1002/art.1780390303

    Article  PubMed  CAS  Google Scholar 

  27. Soares PM, Borba EF, Bonfa E, Hallak J, Corrêa AL, Silva CA (2007) Gonad evaluation in male systemic lupus erythematosus. Arthritis Rheum 56:2352–2361. doi:10.1002/art.22660

    Article  PubMed  Google Scholar 

  28. Suehiro RM, Borba EF, Bonfa E et al (2008) Testicular Sertoli cell function in male systemic lupus erythematosus. Rheumatology 47:1692–1697. doi:10.1093/rheumatology/ken338

    Article  PubMed  CAS  Google Scholar 

  29. Orbach H, Shoenfeld Y (2007) Hyperprolactinemia and autoimmune diseases. Autoimmun Rev 6:537–542. doi:10.1016/j.autrev.2006.10.005

    Article  PubMed  CAS  Google Scholar 

  30. Speroff L, Fritz MA (2005) Amenorrhea. In: Speroff L, Fritz MA (eds) Clinical gynecology endocrinology and infertility, 7th edn. Lippincott Williams and Williams, Philadelphia, pp 401–463

    Google Scholar 

  31. Pasoto SG, Viana VS, Mendonca BB, Yoshinari NH, Bonfa E (1999) Anti-corpus luteum antibody: a novel serological marker for ovarian dysfunction in systemic lupus erythematosus? J Rheumatol 26:1087–1093

    PubMed  CAS  Google Scholar 

  32. Axelrod L (1976) Glucocorticoid therapy. Medicine 55:39–65. doi:10.1097/00005792-197601000-00003

    Article  PubMed  CAS  Google Scholar 

  33. Nelson AM, Conn DL (1980) Series on pharmacology in practice. Glucocorticoids in rheumatic disease. Mayo Clin Proc 55:758–769

    PubMed  CAS  Google Scholar 

  34. Gallant C, Kenny P (1986) Oral glucocorticoids and their complications. A review. J Am Acad Dermatol 14:161–177. doi:10.1016/S0190-9622(86)70018-2

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico–CNPQ (grants 300248/2008-3 to CAAS, 305468/2006-5 to EB, and 301487/2007-3 to MOH) and Federico Foundation Grant to EB. The authors thank the Brazilian Society of Rheumatology and the Brazilian Society of Paediatric, and the following pediatric rheumatologists for evaluating their patients: Rozana G. Almeida, Adriana R. Fonseca, Edson M. Yamashita, Marcos V. Ronchezel, Luciene L. Campos, Simone Appenzeller, Ana B. Santos, Ana C. Medeiros, Luciana M. Carvalho and Silvana P. Cardin. Our gratitude to Ulysses Doria Filho for performing the statistical analysis. This paper was primarily developed in Paediatric Department of Faculdade de Medicina da Universidade de São Paulo, Brazil, in collaboration with a Graduate Student of the Medical Faculty of the Rijks Universiteit Groningen, Netherlands.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Clovis A. Silva.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Silva, C.A., Deen, M.E.J., Febrônio, M.V. et al. Hormone profile in juvenile systemic lupus erythematosus with previous or current amenorrhea. Rheumatol Int 31, 1037–1043 (2011). https://doi.org/10.1007/s00296-010-1389-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-010-1389-2

Keywords

Navigation